Followers | 29 |
Posts | 6477 |
Boards Moderated | 0 |
Alias Born | 05/17/2011 |
Wednesday, March 21, 2018 11:23:25 AM
The chart looks traight shooting up!
Recent BGNE News
- Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors • Business Wire • 09/26/2024 10:00:00 AM
- Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope • AllPennyStocks.com • 09/17/2024 09:01:00 PM
- BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy • Business Wire • 09/17/2024 11:00:00 AM
- Tislelizumab, inibidor PD-1 da BeiGene, é aprovado no Brasil para o tratamento de carcinoma espinocelular de esôfago (ESCC) e câncer de pulmão de células não pequenas (NSCLC) • Business Wire • 09/16/2024 12:00:00 PM
- BeiGene présente les données de TEVIMBRA® sur les cancers pulmonaires et gastro-intestinaux au Congrès de l’ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene präsentiert TEVIMBRA®-Daten bei Lungen- und Magen-Darm-Krebs auf dem ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene annonce la mise à jour de la formation de son équipe de direction commerciale • Business Wire • 09/09/2024 06:52:00 PM
- BeiGene gibt Wechsel im kommerziellen Führungsteam bekannt • Business Wire • 09/09/2024 06:51:00 PM
- BeiGene Announces Updates to Commercial Leadership Team • Business Wire • 09/09/2024 11:00:00 AM
- BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 11:29:23 AM
- BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/28/2024 10:01:00 AM
- BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL • Business Wire • 08/26/2024 10:00:00 AM
- ベイジーン、2024年第2四半期決算および事業に関する最新情報を発表し、グローバル成長の次なる段階へ • Business Wire • 08/08/2024 08:46:00 PM
- BeiGene公布2024年第二季財務業績和公司最新情況,進入全球成長的新階段 • Business Wire • 08/08/2024 12:23:00 PM
- BeiGene startet mit der Bekanntgabe der Finanzergebnisse des zweiten Quartals 2024 und Unternehmens-Updates in die nächste Phase seines globalen Wachstums • Business Wire • 08/08/2024 12:22:00 PM
- BeiGene entame la prochaine phase de sa croissance mondiale en annonçant ses résultats financiers du deuxième trimestre 2024 et des nouvelles de l’entreprise • Business Wire • 08/08/2024 12:22:00 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 08/07/2024 11:32:45 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:04:19 AM
- BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates • Business Wire • 08/07/2024 10:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 08:15:55 PM
- ベイジーン、米国に生物製剤製造および臨床研究開発の旗艦施設を開設し、世界のより多くの患者に医薬品を届けるためのグローバルな拡大を継続 • Business Wire • 07/23/2024 07:10:00 PM
- BeiGene設立美國旗艦生物製劑生產和臨床研發機構,繼續全球擴張,為全球更多病患提供藥品 • Business Wire • 07/23/2024 07:10:00 PM
- BeiGene inaugure un site phare de fabrication de produits biologiques et de R&D clinique aux États-Unis. La société poursuit également son expansion mondiale afin de proposer des médicaments à un plus grand nombre de patients dans le monde entier. • Business Wire • 07/23/2024 05:56:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM